ENTR-01
Idiopathic Pulmonary Fibrosis · WNT/AEC2 Expansion
Clinical trials
1
Mechanism
WNT/AEC2 Expansion
Developer
Entrega Bio
Overview
ENTR-01 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via wnt/aec2 expansion. It appears in 1 tracked IPF clinical trial.
ENTR-01 clinical trials
Explore related
Medical disclaimer. This page summarizes research about ENTR-01 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.